Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2009 Nov 16.
Published in final edited form as: Autophagy. 2007 May 23;3(3):259–262. doi: 10.4161/auto.3906

Autophagy, mitochondria and cell death in lysosomal storage diseases

Kirill Kiselyov 1, John J Jennigs Jr 1, Youssef Rbaibi 1, Charleen T Chu 1,1
PMCID: PMC2777544  NIHMSID: NIHMS132684  PMID: 17329960

Abstract

Lysosomal storage diseases (LSDs) are debilitating genetic conditions that frequently manifest as neurodegenerative disorders. They severely affect eye, motor and cognitive functions and, in most cases, abbreviate the lifespan. Postmitotic cells such as neurons and mononuclear phagocytes rich in lysosomes are most often affected by the accumulation of undegraded material. Cell death is well documented in parts of the brain and in other cells of LSD patients and animal models, although little is known about mechanisms by which death pathways are activated in these diseases, and not all cells exhibiting increased storage material are affected by cell death. Lysosomes are essential for maturation and completion of autophagy-initiated protein and organelle degradation. Moreover, accumulation of effete mitochondria has been documented in postmitotic cells whose lysosomal function is suppressed or in aging cells with lipofuscin accumulation. Based upon observations in the literature and our own data showing similar mitochondrial abnormalities in several LSDs, we propose a new model of cell death in LSDs. We suggest that the lysosomal deficiencies in LSDs inhibit autophagic maturation, leading to a condition of autophagic stress. The resulting accumulation of dysfunctional mitochondria showing impaired Ca2+ buffering increases the vulnerability of the cells to pro-apoptotic signals.

Keywords: autophagy, mitochondrial homeostasis, lysosome, calcium, caspase, programmed cell death, mucolipidosis, neurodegeneration, Niemann-Pick, neuronal ceroid lipofuscinosis


Lysosomal storage diseases (LSDs) comprise >40 rare genetic disorders with cytoplasmic accumulation of lipids, proteins and/or mucopolysaccharides. Some LSDs are caused by inactivating mutations of lysosomal hydrolytic enzymes (e.g. mucopolysaccharidoses) or mutations that affect their delivery to lysosomes (mucolipidoses II-IIIc). Other LSDs involve impaired export of hydrolysis products (cystinoses) 1, 2. The mechanistic etiologies of several LSDs including Niemann-Pick disease remain unexplained.

Most LSDs involve impaired cognitive and motor functions. Loss of neurons is well documented in LSD patients and mouse models 3-10 supporting the concept that the nervous system is particularly susceptible to altered lysosomal function 11. Tissue degeneration also occurs in the liver, spleen and thyroid of affected patients and mice 12. Cell death mechanisms in LSDs may include signaling effects of aberrant lipid/protein composition 6, 13-15, and dysregulation of autophagy 16-18. Similar degenerative phenotypes are observed in unrelated LSDs suggests involvement of common downstream mechanisms, irrespective of the underlying genetic cause of the particular LSD.

Macroautophagy is the major pathway by which organelles are targeted for lysosomal degradation, and this process is essential for basal health of postmitotic cells such as neurons 7, 8. Altered autophagolysosomal function is implicated in aging and a wide range of diseases 19-21. Analysis of disease mechanisms relating to autophagy is complicated by concurrent activation of multiple homeostatic and injury pathways, and growing evidence of regulatory crosstalk between autophagy and apoptosis 22-24. We have proposed a unifying hypothesis that multiple mechanisms resulting in dysregulated or imbalanced induction, maturation, or degradation converge to create the pathologic condition of “autophagic stress” 25, recognized by sustained increases in autophagic vacuoles. Excessive organelle damage and degradation, relative impairments in autophagolysosomal maturation, and differences in co-activated pathways/cellular context may determine whether activation of autophagy plays a pro-survival or pro-death role 25-27, as recently shown for endoplasmic reticulum stress 28. Rapamycin, a drug that inhibits mTOR and stimulates autophagy, shows anti-apoptotic effects 29. Some cell types may be intrinsically less tolerant of autophagic stress than other cell types. While basal autophagy is essential for cellular health, autophagic stress resulting from disruption of finely balanced regulatory mechanisms serves to promote cell death and disease 25.

Mucolipidosis type IV (MLIV) is caused by mutations in the lysosomal ion channel mucolipin 1 (TRP-ML1). TRP-ML1 has been implicated in endosome-lysosome interactions on the basis of lipid traffic delays in TRP-ML1-deficient cells 30. However, lipid trafficking deficits are also observed in LSDs that are clearly linked to hydrolytic defects 31-33. TRP-ML1 could also regulate lysosomal acidity 34. We found that MLIV skin fibroblast cells exhibit accumulation of fragmented mitochondria with impaired Ca2+ buffering capacity, increasing susceptibility to caspase 8-dependent cell death 18. Moreover, similar alterations were observed not only in cells from four different LSDs, but also in normal cells treated with inhibitors of autophagy or lysosomal function 18.

We propose that chronic disruption in lysosomal function, whether due to genetic mutations, drug treatments or aging, promotes cell death through accumulation of mitochondria with impaired abilities to buffer pro-death stresses. In support of this are observations of: i) mitochondrial fragmentation in aged myocytes whose lysosomal function has been impaired by lipofuscin buildup 35; ii) similarities between LSDs and neurodegeneration in mice deficient in central autophagy genes 7, 8 3, 4, 36, and iii) our demonstrations that common patterns of mitochondrial fragmentation and dysfunction in four unrelated LSDs can be recapitulated by multiple distinct pharmacologic inhibitors of autophagy or lysosomal function 18.

In this model, impaired lysosome function results in disrupted autophagy regulation, and accumulation of fragmented, partially dysfunctional mitochondria (Fig 1). As mitochondria balance survival-death stimuli, we hypothesize that increased content of even subtly dysfunctional mitochondria accentuates susceptibility of cells to pro-apoptotic stimuli. Several questions remain to be resolved, including the mechanisms promoting mitochondrial fragmentation. While it is possible that dysregulated fission-fusion due to lipid handling deficits contributes to this LSD phenotype, inhibition of autophagy produces similar fragmentation in control fibroblasts, suggesting inefficient autophagy of mitochondria undergoing fission to facilitate turnover (Fig 1). This interpretation is consistent with the lysosomal-mitochondrial theory of aging 37, 38. It should be noted, however, that mitochondrial morphology is dynamic and mitochondrial fragmentation precedes apoptosis in several systems 39, 40. As LSD cells are more sensitive to apoptosis 18, the possibility remains that mitochondrial fragmentation in our system reflects pre-apoptotic changes.

Fig 1. Mitochondrial fragmentation in LSDs.

Fig 1

In the normal cells, mitochondrial fragments are cleared from the cytoplasm by autophagy followed by lysosomal degradation (Top). In LSD-affected cells, autophagy is suppressed through unknown mechanisms; as a result, mitochondrial fragments with altered functional capacities accumulate (Bottom).

A second question regards the mechanism by which mitochondrial Ca2+ buffering is altered. Using two different assays we showed that uptake of Ca2+ by mitochondria during agonist-induced Ca2+ spikes is deficient in LSD cells. Mitochondrial Ca2+ uptake occurs through mitochondrial Ca2+ uniporters driven by negative mitochondrial membrane potential 41-43. If the shortened mitochondria with dilated cristae are depolarized, this would reduce the driving force for Ca2+ movement. It is also possible that impaired mitochondrial Ca2+ uptake is the result of mitochondrial transition pore opening that accompanies apoptosis, which will also drop mitochondrial membrane potential and induce Ca2+ leakage. Further studies are needed to address these alternatives.

What is the mechanism of cell death in LSDs? While basal apoptosis in MLIV cells are no higher than those of control cells, the former are more sensitive to pro-apoptotic effects of cytoplasmic Ca2+ 18. The commonly accepted Ca2+ excitotoxicity hypothesis links mitochondrial Ca2+ overload and destabilization of mitochondrial membranes 44. Our data show that cell death can occur as a result of inefficient mitochondrial Ca2+ buffering in the absence of “overload”, as mitochondria from LSD cells took up less Ca2+, rather than more Ca2+ as required by the common theory. Thus, it is unlikely that this death pathway is associated with Ca2+-induced permeability transition pore opening, and we did not detect cytochrome c release. Notably, the amounts of Ca2+ accumulated by mitochondria in control cells were relatively small and changes in global Ca2+ signaling associated with LSD or with suppression of autophagy were negligible. Based on these data, we propose that local perimitochondrial changes in Ca2+ handling, rather than global Ca2+ perturbations, are involved in stimulation-induced cell death in LSDs.

Increased caspase 8 activity appeared to be more important than caspase 9 during cell death in Ca2+ stimulated MLIV fibroblasts, and inhibition of caspase 8 conferred protection. Notably, caspase 8 upregulation has been shown in a mouse model Niemann-Pick disease 45 and increased caspase 8 activity is observed in vitro model of Niemann-Pick 46. The mechanisms translating inefficient mitochondrial Ca2+ uptake into caspase-8 activity require further elucidation. It is possible that a population of mitochondria-associated calpains may be involved 47. We have now found that pre-treatment of cells with μ-calpain inhibitors inhibits induced-cell death in MLIV fibroblasts (Fig 2). We hypothesize that during Ca2+ stimulation, perimitochondrial Ca2+ is rapidly cleared by Ca2+ efflux into mitochondria (Fig 3). In LSD cells, reduced mitochondrial buffering results in sufficient perimitochondrial Ca2+ to activate μ-calpains, which could cleave caspase-8 and trigger apoptosis.

Fig 2. Inhibition of μ-calpain suppresses Ca2+-dependent cell death in MLIV fibroblasts.

Fig 2

Cells were pretreated with 1 μM of calpain II (μ-calpain) inhibitor (Calbiochem) for 15 min before experiments and apoptosis was induced as in 18. Note that apoptosis rates of pretreated cells are significantly lower than those of untreated cells. The results represent 3 separate experiments; more than 20 cells were analyzed in each experiment under each condition.

Fig 3. A model of mitochondrial involvement in cell death in LSDs.

Fig 3

In a normal cells during Ca2+ stimulation, perimitochondrial Ca2+ is rapidly cleared into mitochondria. Mitochondria in LSDs-affected cells fail to buffer intracellular increases in Ca2+, potentiating activation of μ-calpain and triggering cell death through caspse-8-dependent mechanisms.

Finally, while it may be assumed that autophagy defects result simply from “backing up” of the degradative system, the situation is likely to be more complex. We observed delayed clearance of starvation-induced autophagy markers upon re-feeding in MLIV fibroblasts 18, suggesting that inefficient autophagosome maturation contributes to autophagic stress in the LSD context. However, differences in regulation of starvation- and injury-initiated autophagy have been reported 48, and our new electron microscopy data indicate that mitochondrial abnormalities observed in LSD cells are not simply the result of impaired degradation. In contrast to lysosomal storage material, which typically accumulates within enlarged lysosomal structures, the electron microscopy data show abnormal mitochondria in the cytoplasm (Fig 4). Thus, lysosomal defects in LSD results not only in delayed autophagosome clearance, but apparently in reduced autophagic sequestration of abnormal mitochondria in the first place, suggesting the existence of unidentified feedback mechanisms. The accumulation of dysfunctional mitochondria in the cytoplasm, rather than as undigested material within lysosomes, plays a critical role in enhanced susceptibiliy to Ca2+ related cell death in MLIV and other LSDs.

Fig 4. Mitochondrial abnormalities in LSDs.

Fig 4

Electron microscopic images of mitochondria in control, MLIV and MLIII fibroblasts. In order to better illustrate the inner mitochondrial structure, large mitochondria were chosen in control and LSDs-affected cells. Please note dilated, distorted cristae (arrows) and dark matrix space in mitochondria from LSDs-affected cells.

Acknowledgements

We would like to extend our apologies to those authors whose work has not been mentioned here due to space limitations. KK is supported by Mucolipidosis IV Foundation and CC is supported by NIH and the Pittsburgh Foundation.

References

  • 1.Mancini GM, Havelaar AC, Verheijen FW. Lysosomal transport disorders. J Inherit Metab Dis. 2000;23:278–92. doi: 10.1023/a:1005640214408. [DOI] [PubMed] [Google Scholar]
  • 2.Mach L. Biosynthesis of lysosomal proteinases in health and disease. Biol Chem. 2002;383:751–6. doi: 10.1515/BC.2002.078. [DOI] [PubMed] [Google Scholar]
  • 3.Walkley SU, Suzuki K. Consequences of NPC1 and NPC2 loss of function in mammalian neurons. Biochim Biophys Acta. 2004;1685:48–62. doi: 10.1016/j.bbalip.2004.08.011. [DOI] [PubMed] [Google Scholar]
  • 4.Sleat DE, Wiseman JA, El-Banna M, Kim KH, Mao Q, Price S, Macauley SL, Sidman RL, Shen MM, Zhao Q, Passini MA, Davidson BL, Stewart GR, Lobel P. A mouse model of classical late-infantile neuronal ceroid lipofuscinosis based on targeted disruption of the CLN2 gene results in a loss of tripeptidyl-peptidase I activity and progressive neurodegeneration. J Neurosci. 2004;24:9117–26. doi: 10.1523/JNEUROSCI.2729-04.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Duggleby W, Bateman J, Singer S. The aging experience of well elderly women: initial results. Nurs Health Sci. 2002;4:A10. [Google Scholar]
  • 6.Tessitore A, del PMM, Sano R, Ma Y, Mann L, Ingrassia A, Laywell ED, Steindler DA, Hendershot LM, d’Azzo A. GM1-ganglioside-mediated activation of the unfolded protein response causes neuronal death in a neurodegenerative gangliosidosis. Mol Cell. 2004;15:753–66. doi: 10.1016/j.molcel.2004.08.029. [DOI] [PubMed] [Google Scholar]
  • 7.Komatsu M, Waguri S, Chiba T, Murata S, Iwata J, Tanida I, Ueno T, Koike M, Uchiyama Y, Kominami E, Tanaka K. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature. 2006;441:880–4. doi: 10.1038/nature04723. [DOI] [PubMed] [Google Scholar]
  • 8.Hara T, Nakamura K, Matsui M, Yamamoto A, Nakahara Y, Suzuki-Migishima R, Yokoyama M, Mishima K, Saito I, Okano H, Mizushima N. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature. 2006;441:885–9. doi: 10.1038/nature04724. [DOI] [PubMed] [Google Scholar]
  • 9.Katz ML, Johnson GS. Mouse gene knockout models for the CLN2 and CLN3 forms of ceroid lipofuscinosis. Eur J Paediatr Neurol. 2001;5(Suppl A):109–14. doi: 10.1053/ejpn.2000.0445. [DOI] [PubMed] [Google Scholar]
  • 10.Folkerth RD, Alroy J, Lomakina I, Skutelsky E, Raghavan SS, Kolodny EH. Mucolipidosis IV: morphology and histochemistry of an autopsy case. J Neuropathol Exp Neurol. 1995;54:154–64. [PubMed] [Google Scholar]
  • 11.Boland B, Nixon RA. Neuronal macroautophagy: from development to degeneration. Mol Aspects Med. 2006;27:503–19. doi: 10.1016/j.mam.2006.08.009. [DOI] [PubMed] [Google Scholar]
  • 12.Beltroy EP, Richardson JA, Horton JD, Turley SD, Dietschy JM. Cholesterol accumulation and liver cell death in mice with Niemann-Pick type C disease. Hepatology. 2005;42:886–93. doi: 10.1002/hep.20868. [DOI] [PubMed] [Google Scholar]
  • 13.Kim EY, Hong YB, Go SH, Lee B, Jung SC. Downregulation of neurotrophic factors in the brain of a mouse model of Gaucher disease; implications for neuronal loss in Gaucher disease. Exp Mol Med. 2006;38:348–56. doi: 10.1038/emm.2006.41. [DOI] [PubMed] [Google Scholar]
  • 14.Huang Z, Hou Q, Cheung NS, Li QT. Neuronal cell death caused by inhibition of intracellular cholesterol trafficking is caspase dependent and associated with activation of the mitochondrial apoptosis pathway. J Neurochem. 2006;97:280–91. doi: 10.1111/j.1471-4159.2006.03733.x. [DOI] [PubMed] [Google Scholar]
  • 15.Walls KC, Klocke BJ, Saftig P, Shibata M, Uchiyama Y, Roth KY, Shacka JJ. Altered Regulation of Phosphatidylinositol 3-kinase Signaling in Cathepsin D-Deficient Brain. Autophagy. 2007:3. doi: 10.4161/auto.3822. [DOI] [PubMed] [Google Scholar]
  • 16.Cao Y, Espinola JA, Fossale E, Massey AC, Cuervo AM, MacDonald ME, Cotman SL. Autophagy is disrupted in a knock-in mouse model of juvenile neuronal ceroid lipofuscinosis. J Biol Chem. 2006;281:20483–93. doi: 10.1074/jbc.M602180200. [DOI] [PubMed] [Google Scholar]
  • 17.Koike M, Shibata M, Waguri S, Yoshimura K, Tanida I, Kominami E, Gotow T, Peters C, Figura Kv, Mizushima N, Saftig P, Uchiyama Y. Participation of autophagy in storage of lysosomes in neurons from mouse models of neuronal ceroid-lipofuscinoses (Batten disease) Am J Pathol. 2005;167:1713–28. doi: 10.1016/S0002-9440(10)61253-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Jennings JJ, Jr., Zhu JH, Rbaibi Y, Luo X, Chu CT, Kiselyov K. Mitochondrial Aberrations in Mucolipidosis Type IV. J Biol Chem. 2006;281:39041–50. doi: 10.1074/jbc.M607982200. [DOI] [PubMed] [Google Scholar]
  • 19.Rubinsztein DC, DiFiglia M, Heintz N, Nixon RA, Qin Z-H, Ravikumar B, Stefanis L, Tolkovsky A. Autophagy and its possible roles in nervous system diseases, damage and repair. Autophagy. 2005;1:11–22. doi: 10.4161/auto.1.1.1513. [DOI] [PubMed] [Google Scholar]
  • 20.Kondo Y, Kanzawa T, Sawaya R, Kondo S. The role of autophagy in cancer development and response to therapy. Nat Rev Cancer. 2005;5:726–34. doi: 10.1038/nrc1692. [DOI] [PubMed] [Google Scholar]
  • 21.Keller JN, Dimayuga E, Chen Q, Thorpe J, Gee J, Ding Q. Autophagy, proteasomes, lipofuscin, and oxidative stress in the aging brain. Int J Biochem Cell Biol. 2004;36:2376–91. doi: 10.1016/j.biocel.2004.05.003. [DOI] [PubMed] [Google Scholar]
  • 22.Pattingre S, Tassa A, Qu X, Garuti R, Liang XH, Mizushima N, Packer M, Schneider MD, Levine B. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell. 2005;122:927–39. doi: 10.1016/j.cell.2005.07.002. [DOI] [PubMed] [Google Scholar]
  • 23.Yousefi S, Perozzo R, Schmid I, Ziemiecki A, Schaffner T, Scapozza L, Brunner T, Simon HU. Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis. Nat Cell Biol. 2006;8:1124–32. doi: 10.1038/ncb1482. [DOI] [PubMed] [Google Scholar]
  • 24.Yu L, Alva A, Su H, Dutt P, Freundt E, Welsh S, Baehrecke EH, Lenardo MJ. Regulation of an ATG7-beclin 1 Program of Autophagic Cell Death by Caspase-8. Science. 2004 doi: 10.1126/science.1096645. [DOI] [PubMed] [Google Scholar]
  • 25.Chu CT. Autophagic stress in neuronal injury and disease. J Neuropathol Exp Neurol. 2006;65:423–32. doi: 10.1097/01.jnen.0000229233.75253.be. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Debnath J, Baehrecke EH, Kroemer G. Does autophagy contribute to cell death? Autophagy. 2005;1-2:66–74. doi: 10.4161/auto.1.2.1738. [DOI] [PubMed] [Google Scholar]
  • 27.Codogno P, Meijer AJ. Autophagy and signaling: their role in cell survival and cell death. Cell Death Differ. 2005;12(Suppl 2):1509–18. doi: 10.1038/sj.cdd.4401751. [DOI] [PubMed] [Google Scholar]
  • 28.Ding WX, Ni HM, Gao W, Hou YF, Melan MA, Chen X, Stolz DB, Shao ZM, Yin XM. Differential effects of endoplasmic reticulum stress-induced autophagy on cell survival. J Biol Chem. 2006 doi: 10.1074/jbc.M609267200. [DOI] [PubMed] [Google Scholar]
  • 29.Ravikumar B, Berger Z, Vacher C, O’Kane CJ, Rubinsztein DC. Rapamycin pre-treatment protects against apoptosis. Hum Mol Genet. 2006;15:1209–16. doi: 10.1093/hmg/ddl036. [DOI] [PubMed] [Google Scholar]
  • 30.Pryor PR, Reimann F, Gribble FM, Luzio JP. Mucolipin-1 Is a Lysosomal Membrane Protein Required for Intracellular Lactosylceramide Traffic. Traffic. 2006;7:1388–98. doi: 10.1111/j.1600-0854.2006.00475.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Chen CS, Patterson MC, Wheatley CL, O’Brien JF, Pagano RE. Broad screening test for sphingolipid-storage diseases. Lancet. 1999;354:901–5. doi: 10.1016/S0140-6736(98)10034-X. [DOI] [PubMed] [Google Scholar]
  • 32.Pagano RE. Endocytic trafficking of glycosphingolipids in sphingolipid storage diseases. Philos Trans R Soc Lond B Biol Sci. 2003;358:885–91. doi: 10.1098/rstb.2003.1275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Sillence DJ, Puri V, Marks DL, Butters TD, Dwek RA, Pagano RE, Platt FM. Glucosylceramide modulates membrane traffic along the endocytic pathway. J Lipid Res. 2002;43:1837–45. doi: 10.1194/jlr.m200232-jlr200. [DOI] [PubMed] [Google Scholar]
  • 34.Soyombo AA, Tjon-Kon-Sang S, Rbaibi Y, Bashllari E, Bisceglia J, Muallem S, Kiselyov K. TRP-ML1 regulates lysosomal pH and acidic lysosomal lipid hydrolytic activity. J Biol Chem. 2006;281:7294–301. doi: 10.1074/jbc.M508211200. [DOI] [PubMed] [Google Scholar]
  • 35.Cuervo AM, Bergamini E, Brunk UT, Droge W, Ffrench M, Terman A. Autophagy and aging: the importance of maintaining “clean” cells. Autophagy. 2005;1:131–40. doi: 10.4161/auto.1.3.2017. [DOI] [PubMed] [Google Scholar]
  • 36.Bonavita S, Virta A, Jeffries N, Goldin E, Tedeschi G, Schiffmann R. Diffuse neuroaxonal involvement in mucolipidosis IV as assessed by proton magnetic resonance spectroscopic imaging. J Child Neurol. 2003;18:443–9. doi: 10.1177/08830738030180070701. [DOI] [PubMed] [Google Scholar]
  • 37.Stroikin Y, Dalen H, Brunk UT, Terman A. Testing the “garbage” accumulation theory of ageing: mitotic activity protects cells from death induced by inhibition of autophagy. Biogerontology. 2005;6:39–47. doi: 10.1007/s10522-004-7382-y. [DOI] [PubMed] [Google Scholar]
  • 38.Brunk UT, Terman A. The mitochondrial-lysosomal axis theory of aging: accumulation of damaged mitochondria as a result of imperfect autophagocytosis. Eur J Biochem. 2002;269:1996–2002. doi: 10.1046/j.1432-1033.2002.02869.x. [DOI] [PubMed] [Google Scholar]
  • 39.Perfettini JL, Roumier T, Kroemer G. Mitochondrial fusion and fission in the control of apoptosis. Trends Cell Biol. 2005;15:179–83. doi: 10.1016/j.tcb.2005.02.005. [DOI] [PubMed] [Google Scholar]
  • 40.Heath-Engel HM, Shore GC. Mitochondrial membrane dynamics, cristae remodelling and apoptosis. Biochim Biophys Acta. 2006;1763:549–60. doi: 10.1016/j.bbamcr.2006.02.006. [DOI] [PubMed] [Google Scholar]
  • 41.Campanella M, Pinton P, Rizzuto R. Mitochondrial Ca2+ homeostasis in health and disease. Biol Res. 2004;37:653–60. doi: 10.4067/s0716-97602004000400022. [DOI] [PubMed] [Google Scholar]
  • 42.Rizzuto R, Bernardi P, Pozzan T. Mitochondria as all-round players of the calcium game. J Physiol. 2000;529(Pt 1):37–47. doi: 10.1111/j.1469-7793.2000.00037.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Parekh AB. Mitochondrial regulation of intracellular Ca2+ signaling: more than just simple Ca2+ buffers. News Physiol Sci. 2003;18:252–6. doi: 10.1152/nips.01458.2003. [DOI] [PubMed] [Google Scholar]
  • 44.Stout AK, Raphael HM, Kanterewicz BI, Klann E, Reynolds IJ. Glutamate-induced neuron death requires mitochondrial calcium uptake. Nat Neurosci. 1998;1:366–73. doi: 10.1038/1577. [DOI] [PubMed] [Google Scholar]
  • 45.Wu YP, Mizukami H, Matsuda J, Saito Y, Proia RL, Suzuki K. Apoptosis accompanied by up-regulation of TNF-alpha death pathway genes in the brain of Niemann-Pick type C disease. Mol Genet Metab. 2005;84:9–17. doi: 10.1016/j.ymgme.2004.08.017. [DOI] [PubMed] [Google Scholar]
  • 46.Koh CH, Qi RZ, Qu D, Melendez A, Manikandan J, Bay BH, Duan W, Cheung NS. U18666A-mediated apoptosis in cultured murine cortical neurons: role of caspases, calpains and kinases. Cell Signal. 2006;18:1572–83. doi: 10.1016/j.cellsig.2005.12.006. [DOI] [PubMed] [Google Scholar]
  • 47.Arrington DD, Van Vleet TR, Schnellmann RG. Calpain 10: a mitochondrial calpain and its role in calcium-induced mitochondrial dysfunction. Am J Physiol Cell Physiol. 2006;291:C1159–71. doi: 10.1152/ajpcell.00207.2006. [DOI] [PubMed] [Google Scholar]
  • 48.Zhu J, Horbinski C, Guo F, Watkins S, Uchiyama Y, Chu CT. Regulation of autophagy by extracellular signal regulated protein kinases during 1-methyl-4-phenylpyridinium induced cell death. American Journal of Pathology. 2007;170:75–86. doi: 10.2353/ajpath.2007.060524. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES